Evidence map›Paper›PMID 28934304›Full record

SynthesisPloS one2017

The significant effects of cerebral microbleeds on cognitive dysfunction: An updated meta-analysis.

Xuanting Li, Junliang Yuan, Lei Yang, Wei Qin, Shuna Yang, Yue Li, Huimin Fan, Wenli Hu

Abstract readMeta-Analysis
In one paragraph

Synthesis in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Lower slow wave sleep and rapid eye movement sleep are associated with brain atrophy of Alzheimer's disease-vulnerable regions.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
    Article
  5. Article
  6. RevealingiScience · 2024
    Article
  7. Atrial fibrillation and dementia: not just a coincidence.Journal of geriatric cardiology : JGC · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Alzheimer disease.Nature reviews. Disease primers · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xuanting LiDepartment of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Junliang YuanDepartment of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Lei YangDepartment of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Wei QinDepartment of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Shuna YangDepartment of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Yue LiDepartment of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Huimin FanDepartment of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Wenli HuDepartment of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0001-6532-5410

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAccumulated data suggests that cerebral microbleeds (CMBs) play an important role in the decline of cognitive function, but the results remain inconsistent. In the current study, we aimed to investigate the association between CMBs and cognitive function, as well as the various effects of CMBs on different domains of cognition.

methodsWe searched through the databases of PubMed, Embase, Cochrane Library, and ScienceDirect. After a consistency test, the publication bias was evaluated and a sensitivity analysis was performed with combined odds ratios (OR) and standardized mean difference (SMD) of CMBs.

resultsA meta-analysis of 25 studies with 9343 participants total was conducted. Patients with CMBs had higher incidence of cognitive impairment (OR:3.5410; 95% confidence interval [CI] [2.2979, 5.4567], p<0.05) and lower scores of cognitive functions (SMD: -0.2700 [-0.4267, -0.1133], p<0.05 in Mini-Mental State Examination [MMSE] group and -0.4869 [-0.8902, -0.0818], p<0.05 in Montreal Cognitive Assessment [MoCA] group). Our results also indicated that patients with CMBs had obvious decline in cognitive functions, for instance, orientation (SMD: -0.9565 [-1.7260, -0.1869], p<0.05), attention and calculation (SMD: -1.1518 [-1.9553, -0.3484], p<0.05) and delayed recall (SMD: -0.5527 [-1.1043, -0.0011], p = 0.05).

conclusionsOur data suggested that CMBs might be an important risk factor for cognitive dysfunction, especially in the domains of orientation, attention and calculation and delayed recall functions. Prospective cohort studies with further investigations will be needed in larger samples.

Indexed as

Cerebral HemorrhageCognitive DysfunctionHumans

Identifiers

PMID28934304
PMCPMC5608335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.